Forum

Exploration of strategies for improving clinical research level in medical universities

  • Li KANG ,
  • Wei WANG ,
  • Tienan FENG ,
  • Tingting CUI ,
  • Suping WANG
Expand
  • 1.Office of Academic Planning and Development, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2.Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    3.Library, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    4.China Hospital Development Institute, Shanghai Jiao Tong University, Shanghai 200025, China
WANG Suping, E-mail: wangsuping@shsmu.edu.cn.

Received date: 2024-06-29

  Accepted date: 2024-07-31

  Online published: 2024-09-28

Supported by

National Key Research and Development Program of China(2020YFC2006400)

Abstract

Objective ·To analyze the development trend and current situation of high-level clinical research at Shanghai Jiao Tong University School of Medicine (SJTUSM) from 2015 to 2023, and to summarize the strategies for improving clinical research capability of SJTUSM, aiming to provide reference and inspiration for medical universities to promote high-level clinical research. Methods ·Papers published by first authors from SJTUSM or its affiliated hospitals during this period were retrieved in the Web of Science core collection database. General descriptive methods were used to quantify the number of clinical research papers, registered clinical trials, clinical research talent teams, and the current status of clinical research cooperation. Bibliometric methods were used to visualize the international collaboration and topic distribution of retrieved clinical research papers. The differences in the number of clinical research publications, Q1 publications, publications in top clinical medical journals, and full-time researchers between the periods of 2015?2018 and 2019?2023 were compared and analyzed. Results ·From 2015 to 2023, a total of 9 468 clinical research papers were published by SJTUSM or its affiliated hospitals as the first author′s institution, showing an increasing trend year by year. During this period, the number of Q1 publications of SJTUSM′s clinical research, publications in top clinical medical journals, clinical studies registered on the United States Clinical Trial Registry website, clinical studies registered on the Chinese Clinical Trial Registry website, clinical guidelines and expert consensus publications, full-time research team members, and newly added national-level talents all showed an overall upward trend. Tumors, cardiovascular and cerebrovascular diseases, major chronic diseases, and mental illnesses were the main research hotspots. A total of 1 308 papers (13.82%) were international collaborative papers. Developed countries/regions such as the United States (733 papers), Australia (137 papers), and the United Kingdom (99 papers) were closely cooperating with SJTUSM. From 2019 to 2023, there was a significant increase in the number of clinical research papers, Q1 publications, publications in top clinical medical journals, and newly added full-time research team members in affiliated hospitals compared to the period from 2015 to 2018 (all P<0.05). Conclusion ·SJTUSM has strengthened top-level design, conducted in-depth major diseases, and constructed a systematic, integrated and closed-loop model for enhancing clinical research level along the “platform-talent-methodology” pathway, resulting in a number of high-quality clinical research outcomes.

Cite this article

Li KANG , Wei WANG , Tienan FENG , Tingting CUI , Suping WANG . Exploration of strategies for improving clinical research level in medical universities[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(9) : 1197 -1204 . DOI: 10.3969/j.issn.1674-8115.2024.09.015

References

1 李春红, 施琼芸, 张晓波, 等. 医学院校附属医院内设基础与转化研究平台建设策略[J]. 中国医院管理, 2023, 43(12): 74-76, 83.
1 LI C H, SHI Q Y, ZHANG X B, et al. The strategy of building basic research and translational medicine institute in affiliated hospital of medical schools[J]. Chinese Hospital Management, 2023, 43(12): 74-76, 83.
2 沈慧青, 舒之群, 吴皓, 等. 上海某市级医院临床研究体系建设探索与思考[J]. 中国研究型医院, 2021, 8(3): 26-29.
2 SHEN H Q, SHU Z Q, WU H, et al. The exploration and thinking on clinical research system construction in municipal hospital of Shanghai[J]. Journal of Chinese Research Hospital, 2021, 8(3):26-29.
3 贾硕鹏, 黄慧瑶, 冷烨, 等. 国际多中心临床试验在中国实施的监管历程和科学性挑战[J]. 癌症, 2023, 42(12): 607-613.
3 JIA S P, HUANG H Y, LENG Y, et al. The regulatory process and scientific challenges of international multicenter clinical trials implemented in China[J]. Chinese Journal of Cancer, 2023, 42(12): 607-613.
4 罗娟. 国际多中心临床试验在中国: 专访中国抗癌协会临床肿瘤协作专业委员会主任委员吴一龙教授[J]. 中国新药杂志, 2014, 23(19): 前插4-前插6.
4 LUO J. International multicenter clinical trials in China: interview with Professor Wu Yilong, Chairman of the Clinical Oncology Collaboration Professional Committee of the Chinese Anti-Cancer Association[J]. Chinese Journal of New Drugs, 2014, 23(19): Insert 4-Insert 6.
5 李玲,樊春良. 转化医学的理论演化及其发展的主要问题[J]. 医学与哲学, 2021, 42(6): 22-27.
5 LI L, FAN C L. Theory evolution and development problems of translational medicine[J]. Medicine & Philosophy, 2021, 42(6): 22-27.
6 雷翔, 王晓晖, 李静, 等. 中国临床试验CRO的发展与变革[J]. 中国循证医学杂志, 2018, 18(8): 783-786.
6 LEI X, WANG X H, LI J, et al. Development and changes of CRO of clinical trials in China[J]. Chinese Journal of Evidence-Based Medicine, 2018, 18(8): 783-786.
Outlines

/